Enovis (ENOV) Total Current Liabilities (2010 - 2026)
Enovis (ENOV) posted quarterly Total Current Liabilities of $608.7 million for Q2 2026, up 27.49% year-over-year from $477.4 million in Q2 2025, and up 1.7% quarter-over-quarter from $598.5 million in Q4 2025.
Enovis (ENOV) Total Current Liabilities (2010 - 2026) Analysis & Trends
Enovis (ENOV) has reported Total Current Liabilities for 17 consecutive years, with $608.7 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Total Current Liabilities rose 27.49% year-over-year to $608.7 million; the TTM figure through Apr 2026 stood at $608.7 million (up 27.49% YoY), while the FY2025 annual figure was $598.5 million, up 13.13% from the prior year.
- Total Current Liabilities climbed to $608.7 million in Q2 2026 per ENOV's latest filing, from $598.5 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $1.5 billion in Q2 2022 and bottomed at $349.5 million in Q1 2023.
- Historically, Total Current Liabilities has averaged $592.0 million across 5 years, with a median of $549.1 million in 2024.
- Annual changes were most pronounced in 2023 — Total Current Liabilities tumbled 75.9% — and 2024, when it surged 57.12%.
- Enovis' Total Current Liabilities stood at $565.2 million in 2022, then tumbled by 34.61% to $369.6 million in 2023, then surged by 43.12% to $529.0 million in 2024, then climbed by 13.13% to $598.5 million in 2025, then climbed by 1.7% to $608.7 million in 2026.
- Business Quant data shows ENOV's Total Current Liabilities at $608.7 million in Q2 2026, $598.5 million in Q4 2025, and $575.4 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.24 Bn | 193.64 Bn | 7.27 Bn | 17.81 Bn |
| 2 | Stryker | 128.63 Bn | 125.15 Bn | 4.50 Bn | 6.68 Bn |
| 3 | Medtronic | 119.19 Bn | 109.97 Bn | 6.41 Bn | 11.66 Bn |
| 4 | Boston Scientific | 73.51 Bn | 72.97 Bn | 3.85 Bn | 6.43 Bn |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.85 Bn | 1.35 Bn | 1.51 Bn |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn | 2.36 Bn |
| 7 | GE HealthCare Technologies | 34.01 Bn | 31.90 Bn | 2.18 Bn | 8.30 Bn |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn | 8.63 Bn |
| 9 | Steris | 23.14 Bn | 22.65 Bn | 684.20 Mn | 1.28 Bn |
| 10 | Enovis | 1.52 Bn | 1.51 Bn | 359.25 Mn | 612.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 3, 2026 | 612.05 Mn |
| Apr 3, 2026 | 608.67 Mn |
| Dec 31, 2025 | 598.47 Mn |
| Oct 3, 2025 | 575.44 Mn |
| Jul 4, 2025 | 568.18 Mn |
| Apr 4, 2025 | 477.42 Mn |
| Dec 31, 2024 | 529.00 Mn |
| Sep 27, 2024 | 530.22 Mn |
| Jun 28, 2024 | 518.01 Mn |
| Mar 29, 2024 | 549.13 Mn |
| Dec 31, 2023 | 369.61 Mn |
| Sep 29, 2023 | 355.28 Mn |
| Jun 30, 2023 | 353.67 Mn |
| Mar 31, 2023 | 349.50 Mn |
| Dec 31, 2022 | 565.20 Mn |
| Sep 30, 2022 | 853.92 Mn |
| Jul 1, 2022 | 812.80 Mn |
| Apr 1, 2022 | 1.45 Bn |
| Dec 31, 2021 | 1.02 Bn |
| Oct 1, 2021 | 975.47 Mn |